The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Emerging therapies in cancer metabolism
Open accessAbstract
Metabolic reprogramming in cancer is not only a biological hallmark but also reveals treatment vulnerabilities. Numerous metabolic molecules have shown promise as treatment targets to impede tumor progression in preclinical studies, with some advancing to clinical trials. However, the intricacy and adaptability of metabolic networks hinder the effectiveness of metabolic therapies. This review summarizes the metabolic targets for cancer treatment and provides an overview of the current status of clinical trials targeting cancer metabolism. Additionally, we decipher crucial factors that limit the efficacy of metabolism-based therapies and propose future directions. With advances in integrating multi-omics, single-cell, and spatial technologies, as well as the ability to track metabolic adaptation more precisely and dynamically, clinicians can personalize metabolic therapies for improved cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Hallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
What is flux balance analysis?
Orth, J. D., Thiele, I., & Palsson, B. Ø. (2010) · Nature Biotechnology · doi:10.1038/nbt.1614 · Cited by 3,903
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Metabolic reprogramming and cancer progression
Faubert, B., Solmonson, A., & DeBerardinis, R. J. (2020) · Science · doi:10.1126/science.aaw5473 · Cited by 2,740
Targeting Ferroptosis as a Vulnerability in Cancer
Lei, G., Zhuang, L., & Gan, B. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00459-0 · Cited by 2,252
Top 10 Challenges in Cancer Immunotherapy
Hegde, P. S., & Chen, D. S. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.011 · Cited by 2,238
Jha, A. K., Huang, S. C.-C., Sergushichev, A., Lampropoulou, V., Ivanova, Y., Loginicheva, E., Chmielewski, K., Stewart, K. M., Ashall, J., Everts, B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.005 · Cited by 2,066
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806
L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Geiger, R., Rieckmann, J. C., Wolf, T., Basso, C., Feng, Y., Fuhrer, T., Kogadeeva, M., Picotti, P., Meissner, F., Mann, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.031 · Cited by 1,775
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
Morad, G., Helmink, B. A., Sharma, P., & Wargo, J. A. (2021) · Cell · doi:10.1016/j.cell.2021.09.020 · Cited by 1,648
The role of ROS in tumour development and progression
Cheung, E. C., & Vousden, K. H. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00435-0 · Cited by 1,595
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Platten, M., Nollen, E. A. A., Röhrig, U. F., Fallarino, F., & Opitz, C. A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0016-5 · Cited by 1,586
Durable Remissions with Ivosidenib in IDH1 -Mutated Relapsed or Refractory AML
DiNardo, C. D., Stein, E. M., de Botton, S., Roboz, G. J., Altman, J. K., Mims, A. S., Swords, R., Collins, R. H., Mannis, G. N., Pollyea, D. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716984 · Cited by 1,454
Yachida, S., Mizutani, S., Shiroma, H., Shiba, S., Nakajima, T., Sakamoto, T., Watanabe, H., Masuda, K., Nishimoto, Y., Kubo, M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0458-7 · Cited by 1,429
The hallmarks of cancer metabolism: still emerging
Pavlova, N. N., Zhu, J., & Thompson, C. B. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.007 · Cited by 1,418
Ferroptosis at the intersection of lipid metabolism and cellular signaling
Liang, D., Minikes, A. M., & Jiang, X. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.03.022 · Cited by 1,345
The cancer metabolic reprogramming and immune response
Xia, L., Oyang, L., Lin, J., Tan, S., Han, Y., Wu, N., Yi, P., Tang, L., Pan, Q., Rao, S., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01316-8 · Cited by 1,312
Miwa, M., Ura, M., Nishida, M., Sawada, N., Ishikawa, T., Mori, K., Shimma, N., Umeda, I., & Ishitsuka, H. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00058-6 · Cited by 1,240
Targeting cancer metabolism in the era of precision oncology
Stine, Z. E., Schug, Z. T., Salvino, J. M., & Dang, C. V. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00339-6 · Cited by 1,189
Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
Ashton, T. M., McKenna, W. G., Kunz-Schughart, L. A., & Higgins, G. S. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3070 · Cited by 1,135
Alseekh, S., Aharoni, A., Brotman, Y., Contrepois, K., D’Auria, J., Ewald, J., C. Ewald, J., Fraser, P. D., Giavalisco, P., Hall, R. D., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01197-1 · Cited by 1,128
Self-citationAbou-Alfa, G. K., Macarulla, T., Javle, M. M., Kelley, R. K., Lubner, S. J., Adeva, J., Cleary, J. M., Catenacci, D. V., Borad, M. J., Bridgewater, J., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30157-1 · Cited by 1,116
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
Wheaton, W. W., Weinberg, S. E., Hamanaka, R. B., Soberanes, S., Sullivan, L. B., Anso, E., Glasauer, A., Dufour, E., Mutlu, G. M., Budigner, G. S., et al. (2014) · eLife · doi:10.7554/elife.02242 · Cited by 1,105
Cell-programmed nutrient partitioning in the tumour microenvironment
Reinfeld, B. I., Madden, M. Z., Wolf, M. M., Chytil, A., Bader, J. E., Patterson, A. R., Sugiura, A., Cohen, A. S., Ali, A., Do, B. T., et al. (2021) · Nature · doi:10.1038/s41586-021-03442-1 · Cited by 1,023
Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism
Yang, W., Bai, Y., Xiong, Y., Zhang, J., Chen, S., Zheng, X., Meng, X., Li, L., Wang, J., Xu, C., et al. (2016) · Nature · doi:10.1038/nature17412 · Cited by 1,010
Identification of bioactive metabolites using activity metabolomics
Rinschen, M. M., Ivanisevic, J., Giera, M., & Siuzdak, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0108-4 · Cited by 1,008
Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells
Maddocks, O. D. K., Berkers, C. R., Mason, S. M., Zheng, L., Blyth, K., Gottlieb, E., & Vousden, K. H. (2013) · Nature · doi:10.1038/nature11743 · Cited by 1,007
Long, G. V., Dummer, R., Hamid, O., Gajewski, T. F., Caglevic, C., Dalle, S., Arance, A., Carlino, M. S., Grob, J.-J., Kim, T. M., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30274-8 · Cited by 960
Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities
Huang, B., Song, B.-L., & Xu, C. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0174-0 · Cited by 921
CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4
Liao, P., Wang, W., Wang, W., Kryczek, I., Li, X., Bian, Y., Sell, A., Wei, S., Grove, S., Johnson, J. K., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.02.003 · Cited by 912
Kumagai, S., Koyama, S., Itahashi, K., Tanegashima, T., Lin, Y.-T., Togashi, Y., Kamada, T., Irie, T., Okumura, G., Kono, H., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.01.001 · Cited by 892
Metabolism of immune cells in cancer
Leone, R. D., & Powell, J. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0273-y · Cited by 877
Wang, T., Fahrmann, J. F., Lee, H., Li, Y.-J., Tripathi, S. C., Yue, C., Zhang, C., Lifshitz, V., Song, J., Yuan, Y., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.001 · Cited by 825
Metabolomics and Isotope Tracing
Jang, C., Chen, L., & Rabinowitz, J. D. (2018) · Cell · doi:10.1016/j.cell.2018.03.055 · Cited by 825
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
Hakimi, A. A., Reznik, E., Lee, C.-H., Creighton, C. J., Brannon, A. R., Luna, A., Aksoy, B. A., Liu, E. M., Shen, R., Lee, W., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.004 · Cited by 798
The Next Decade of Immune Checkpoint Therapy
Sharma, P., Siddiqui, B. A., Anandhan, S., Yadav, S. S., Subudhi, S. K., Gao, J., Goswami, S., & Allison, J. P. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1680 · Cited by 750
Hezaveh, K., Shinde, R. S., Klötgen, A., Halaby, M. J., Lamorte, S., Ciudad, M. T., Quevedo, R., Neufeld, L., Liu, Z. Q., Jin, R., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.01.006 · Cited by 746
Rysman, E., Brusselmans, K., Scheys, K., Timmermans, L., Derua, R., Munck, S., Van Veldhoven, P. P., Waltregny, D., Daniëls, V. W., Machiels, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3871 · Cited by 721
Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy
Lee, C., Raffaghello, L., Brandhorst, S., Safdie, F. M., Bianchi, G., Martin-Montalvo, A., Pistoia, V., Wei, M., Hwang, S., Merlino, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003293 · Cited by 715
Chen, F., Chen, J., Yang, L., Liu, J., Zhang, X., Zhang, Y., Tu, Q., Yin, D., Lin, D., Wong, P.-P., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0299-0 · Cited by 712
Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
Hopkins, B. D., Pauli, C., Du, X., Wang, D. G., Li, X., Wu, D., Amadiume, S. C., Goncalves, M. D., Hodakoski, C., Lundquist, M. R., et al. (2018) · Nature · doi:10.1038/s41586-018-0343-4 · Cited by 706
Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline
Ligibel, J. A., Bohlke, K., May, A. M., Clinton, S. K., Demark-Wahnefried, W., Gilchrist, S. C., Irwin, M. L., Late, M., Mansfield, S., Marshall, T. F., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.00687 · Cited by 700
Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).
Hertel, L. W., Boder, G. B., Kroin, J. S., Rinzel, S. M., Poore, G. A., Todd, G. C., & Grindey, G. B. (1990) · PubMed · Cited by 680
Metabolic programming and immune suppression in the tumor microenvironment
Arner, E. N., & Rathmell, J. C. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.01.009 · Cited by 668
Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma
Ravi, V. M., Will, P., Kueckelhaus, J., Sun, N., Joseph, K., Salié, H., Vollmer, L., Kuliesiute, U., von Ehr, J., Benotmane, J. K., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.05.009 · Cited by 663
Dietary methionine influences therapy in mouse cancer models and alters human metabolism
Gao, X., Sanderson, S. M., Dai, Z., Reid, M. A., Cooper, D. E., Lu, M., Richie, J. P., Ciccarella, A., Calcagnotto, A., Mikhael, P. G., et al. (2019) · Nature · doi:10.1038/s41586-019-1437-3 · Cited by 636
Yang, F., Xiao, Y., Ding, J.-H., Jin, X., Ma, D., Li, D.-Q., Shi, J.-X., Huang, W., Wang, Y.-P., Jiang, Y.-Z., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.021 · Cited by 624
Self-citationSalinomycin kills cancer stem cells by sequestering iron in lysosomes
Mai, T. T., Hamaï, A., Hienzsch, A., Cañeque, T., Müller, S., Wicinski, J., Cabaud, O., Leroy, C., David, A., Acevedo, V., et al. (2017) · Nature Chemistry · doi:10.1038/nchem.2778 · Cited by 612
Mechanisms and Implications of Metabolic Heterogeneity in Cancer
Kim, J., & DeBerardinis, R. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.013 · Cited by 606
Modulating the therapeutic response of tumours to dietary serine and glycine starvation
Maddocks, O. D. K., Athineos, D., Cheung, E. C., Lee, P., Zhang, T., van den Broek, N. J. F., Mackay, G. M., Labuschagne, C. F., Gay, D., Kruiswijk, F., et al. (2017) · Nature · doi:10.1038/nature22056 · Cited by 603
Abdel-Wahab, A. F., Mahmoud, W., & Al-Harizy, R. M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104511 · Cited by 591
NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications
Ju, H.-Q., Lin, J.-F., Tian, T., Xie, D., & Xu, R.-H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00326-0 · Cited by 581
Argüello, R. J., Combes, A. J., Char, R., Gigan, J.-P., Baaziz, A. I., Bousiquot, E., Camosseto, V., Samad, B., Tsui, J., Yan, P., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.007 · Cited by 577
Hallmarks of cancer stem cell metabolism
Sancho, P., Barneda, D., & Heeschen, C. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.152 · Cited by 574
The emerging role and targetability of the TCA cycle in cancer metabolism
Anderson, N. M., Mucka, P., Kern, J. G., & Feng, H. (2018) · Protein & Cell · doi:10.1007/s13238-017-0451-1 · Cited by 556
Ferroptosis of tumour neutrophils causes immune suppression in cancer
Kim, R., Hashimoto, A., Markosyan, N., Tyurin, V. A., Tyurina, Y. Y., Kar, G., Fu, S., Sehgal, M., Garcia-Gerique, L., Kossenkov, A., et al. (2022) · Nature · doi:10.1038/s41586-022-05443-0 · Cited by 545
Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade
Ferrere, G., Tidjani Alou, M., Liu, P., Goubet, A.-G., Fidelle, M., Kepp, O., Durand, S., Iebba, V., Fluckiger, A., Daillère, R., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.145207 · Cited by 533
The landscape of cancer cell line metabolism
Li, H., Ning, S., Ghandi, M., Kryukov, G. V., Gopal, S., Deik, A., Souza, A., Pierce, K., Keskula, P., Hernandez, D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0404-8 · Cited by 525
Fasting and cancer: molecular mechanisms and clinical application
Nencioni, A., Caffa, I., Cortellino, S., & Longo, V. D. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0061-0 · Cited by 518
Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis
Chen, G.-Q., Benthani, F. A., Wu, J., Liang, D., Bian, Z.-X., & Jiang, X. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0352-3 · Cited by 509
Zhu, A. X., Macarulla, T., Javle, M. M., Kelley, R. K., Lubner, S. J., Adeva, J., Cleary, J. M., Catenacci, D. V. T., Borad, M. J., Bridgewater, J. A., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.3836 · Cited by 509
Avramis, V. I., Sencer, S., Periclou, A. P., Sather, H., Bostrom, B. C., Cohen, L. J., Ettinger, A. G., Ettinger, L. J., Franklin, J., Gaynon, P. S., et al. (2002) · Blood · doi:10.1182/blood.v99.6.1986 · Cited by 492
Tumours with PI3K activation are resistant to dietary restriction
Kalaany, N. Y., & Sabatini, D. M. (2009) · Nature · doi:10.1038/nature07782 · Cited by 468
Gong, Y., Ji, P., Yang, Y.-S., Xie, S., Yu, T.-J., Xiao, Y., Jin, M.-L., Ma, D., Guo, L.-W., Pei, Y.-C., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.012 · Cited by 467
Self-citationNucleotide metabolism: a pan-cancer metabolic dependency
Mullen, N. J., & Singh, P. K. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00557-7 · Cited by 466
Oh, M.-H., Sun, I.-H., Zhao, L., Leone, R. D., Sun, I.-M., Xu, W., Collins, S. L., Tam, A. J., Blosser, R. L., Patel, C. H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci131859 · Cited by 456
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
Coyle, C., Cafferty, F. H., Vale, C., & Langley, R. E. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw410 · Cited by 452
Schoenfeld, J. D., Sibenaller, Z. A., Mapuskar, K. A., Wagner, B. A., Cramer-Morales, K. L., Furqan, M., Sandhu, S., Carlisle, T. L., Smith, M. C., Abu Hejleh, T., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.018 · Cited by 443
NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism
Chen, L., Zhang, Z., Hoshino, A., Zheng, H. D., Morley, M., Arany, Z., & Rabinowitz, J. D. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0043-x · Cited by 423
Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer
Halbrook, C. J., Pontious, C., Kovalenko, I., Lapienyte, L., Dreyer, S., Lee, H.-J., Thurston, G., Zhang, Y., Lazarus, J., Sajjakulnukit, P., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.001 · Cited by 419
Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity
Feng, Q., Liu, Z., Yu, X., Huang, T., Chen, J., Wang, J., Wilhelm, J., Li, S., Song, J., Li, W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32521-8 · Cited by 419
Clavell, L. A., Gelber, R. D., Cohen, H. J., Hitchcock-Bryan, S., Cassady, J. R., Tarbell, N. J., Blattner, S. R., Tantravahi, R., Leavitt, P., & Sallan, S. E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609113151101 · Cited by 416
Wang, H., Rong, X., Zhao, G., Zhou, Y., Xiao, Y., Ma, D., Jin, X., Wu, Y., Yan, Y., Yang, H., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.02.010 · Cited by 411
Self-citationREGRESSION OF TRANSPLANTED LYMPHOMAS INDUCED IN VIVO BY MEANS OF NORMAL GUINEA PIG SERUM
Kidd, J. G. (1953) · Journal of Experimental Medicine · doi:10.1084/jem.98.6.565 · Cited by 410
Yap, T. A., Daver, N., Mahendra, M., Zhang, J., Kamiya-Matsuoka, C., Meric-Bernstam, F., Kantarjian, H. M., Ravandi, F., Collins, M. E., Francesco, M. E. D., et al. (2023) · Nature Medicine · doi:10.1038/s41591-022-02103-8 · Cited by 401
Zhu, H., Bi, D., Zhang, Y., Kong, C., Du, J., Wu, X., Wei, Q., & Qin, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00831-w · Cited by 399
Tumour fatty acid metabolism in the context of therapy resistance and obesity
Hoy, A. J., Nagarajan, S. R., & Butler, L. M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00388-4 · Cited by 392
Mitchell, T. C., Hamid, O., Smith, D. C., Bauer, T. M., Wasser, J. S., Olszanski, A. J., Luke, J. J., Balmanoukian, A. S., Schmidt, E. V., Zhao, Y., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.9602 · Cited by 388
Agren, R., Mardinoglu, A., Asplund, A., Kampf, C., Uhlen, M., & Nielsen, J. (2014) · Molecular Systems Biology · doi:10.1002/msb.145122 · Cited by 387
Spatially resolved metabolomics to discover tumor-associated metabolic alterations
Sun, C., Li, T., Song, X., Huang, L., Zang, Q., Xu, J., Bi, N., Jiao, G., Hao, Y., Chen, Y., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808950116 · Cited by 364
Fasting-mimicking diet and hormone therapy induce breast cancer regression
Caffa, I., Spagnolo, V., Vernieri, C., Valdemarin, F., Becherini, P., Wei, M., Brandhorst, S., Zucal, C., Driehuis, E., Ferrando, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2502-7 · Cited by 355
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities
Kim, T. K., Vandsemb, E. N., Herbst, R. S., & Chen, L. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00493-5 · Cited by 351
Polyamines in cancer: integrating organismal metabolism and antitumour immunity
Holbert, C. E., Cullen, M. T., Casero, R. A., & Stewart, T. M. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00473-2 · Cited by 350
Metabolic communication in the tumour–immune microenvironment
Kao, K.-C., Vilbois, S., Tsai, C.-H., & Ho, P.-C. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-01002-x · Cited by 349
EVIDENCE THAT THE L-ASPARAGINASE OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTS
Broome, J. D. (1963) · The Journal of Experimental Medicine · doi:10.1084/jem.118.1.99 · Cited by 348
Biological Role and Therapeutic Potential of IDH Mutations in Cancer
Waitkus, M. S., Diplas, B. H., & Yan, H. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.04.011 · Cited by 335
L-asparaginase in the treatment of patients with acute lymphoblastic leukemia
Egler, R. A., Ahuja, S. P., & Matloub, Y. (2016) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.184769 · Cited by 334
Fatty acid synthesis is required for breast cancer brain metastasis
Ferraro, G. B., Ali, A., Luengo, A., Kodack, D. P., Deik, A., Abbott, K. L., Bezwada, D., Blanc, L., Prideaux, B., Jin, X., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00183-y · Cited by 326
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
Xiao, Y., Ma, D., Yang, Y.-S., Yang, F., Ding, J.-H., Gong, Y., Jiang, L., Ge, L.-P., Wu, S.-Y., Yu, Q., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00614-0 · Cited by 326
Self-citationA systematic analysis of FDA-approved anticancer drugs
Sun, J., Wei, Q., Zhou, Y., Wang, J., Liu, Q., & Xu, H. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0464-7 · Cited by 322
Finley, L. W. S. (2023) · Cell · doi:10.1016/j.cell.2023.01.038 · Cited by 322
Cancer-cell-derived GABA promotes β-catenin-mediated tumour growth and immunosuppression
Huang, D., Wang, Y., Thompson, J. W., Yin, T., Alexander, P. B., Qin, D., Mudgal, P., Wu, H., Liang, Y., Tan, L., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-021-00820-9 · Cited by 317
Self-citationβ-Hydroxybutyrate suppresses colorectal cancer
Dmitrieva-Posocco, O., Wong, A. C., Lundgren, P., Golos, A. M., Descamps, H. C., Dohnalová, L., Cramer, Z., Tian, Y., Yueh, B., Eskiocak, O., et al. (2022) · Nature · doi:10.1038/s41586-022-04649-6 · Cited by 317
Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy
Fendt, S.-M., Frezza, C., & Erez, A. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0844 · Cited by 313
PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers
Gentric, G., Kieffer, Y., Mieulet, V., Goundiam, O., Bonneau, C., Nemati, F., Hurbain, I., Raposo, G., Popova, T., Stern, M.-H., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.002 · Cited by 310
Oncometabolites suppress DNA repair by disrupting local chromatin signalling
Sulkowski, P. L., Oeck, S., Dow, J., Economos, N. G., Mirfakhraie, L., Liu, Y., Noronha, K., Bao, X., Li, J., Shuch, B. M., et al. (2020) · Nature · doi:10.1038/s41586-020-2363-0 · Cited by 308
Low glycaemic diets alter lipid metabolism to influence tumour growth
Lien, E. C., Westermark, A. M., Zhang, Y., Yuan, C., Li, Z., Lau, A. N., Sapp, K. M., Wolpin, B. M., & Vander Heiden, M. G. (2021) · Nature · doi:10.1038/s41586-021-04049-2 · Cited by 308
Metabolomics and mass spectrometry imaging reveal channeled de novo purine synthesis in cells
Pareek, V., Tian, H., Winograd, N., & Benkovic, S. J. (2020) · Science · doi:10.1126/science.aaz6465 · Cited by 307
GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
Wu, Q., ba-alawi, W., Deblois, G., Cruickshank, J., Duan, S., Lima-Fernandes, E., Haight, J., Tonekaboni, S. A. M., Fortier, A.-M., Kuasne, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18020-8 · Cited by 305
NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion
Lv, H., Lv, G., Chen, C., Zong, Q., Jiang, G., Ye, D., Cui, X., He, Y., Xiang, W., Han, Q., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.021 · Cited by 301
The therapeutic potential of targeting tryptophan catabolism in cancer
Opitz, C. A., Somarribas Patterson, L. F., Mohapatra, S. R., Dewi, D. L., Sadik, A., Platten, M., & Trump, S. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0664-6 · Cited by 300
Slow TCA flux and ATP production in primary solid tumours but not metastases
Bartman, C. R., Weilandt, D. R., Shen, Y., Lee, W. D., Han, Y., TeSlaa, T., Jankowski, C. S. R., Samarah, L., Park, N. R., da Silva-Diz, V., et al. (2023) · Nature · doi:10.1038/s41586-022-05661-6 · Cited by 299
Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY‐876
Siebeneicher, H., Cleve, A., Rehwinkel, H., Neuhaus, R., Heisler, I., Müller, T., Bauser, M., & Buchmann, B. (2016) · ChemMedChem · doi:10.1002/cmdc.201600276 · Cited by 294
Neurons release serine to support mRNA translation in pancreatic cancer
Banh, R. S., Biancur, D. E., Yamamoto, K., Sohn, A. S. W., Walters, B., Kuljanin, M., Gikandi, A., Wang, H., Mancias, J. D., Schneider, R. J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.016 · Cited by 292
Zadra, G., Ribeiro, C. F., Chetta, P., Ho, Y., Cacciatore, S., Gao, X., Syamala, S., Bango, C., Photopoulos, C., Huang, Y., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808834116 · Cited by 291
Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets
Kopecka, J., Trouillas, P., Gašparović, A. Č., Gazzano, E., Assaraf, Y. G., & Riganti, C. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100670 · Cited by 291
Linoleic acid potentiates CD8+ T cell metabolic fitness and antitumor immunity
Nava Lauson, C. B., Tiberti, S., Corsetto, P. A., Conte, F., Tyagi, P., Machwirth, M., Ebert, S., Loffreda, A., Scheller, L., Sheta, D., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.02.013 · Cited by 291
Evolving concepts in NAD+ metabolism
Chini, C. C. S., Zeidler, J. D., Kashyap, S., Warner, G., & Chini, E. N. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.04.003 · Cited by 288
Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy
Yang, W.-H., Qiu, Y., Stamatatos, O., Janowitz, T., & Lukey, M. J. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2021.04.003 · Cited by 287
Rios Garcia, M., Steinbauer, B., Srivastava, K., Singhal, M., Mattijssen, F., Maida, A., Christian, S., Hess-Stumpp, H., Augustin, H. G., Müller-Decker, K., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.018 · Cited by 274
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer
Sampath, D., Zabka, T. S., Misner, D. L., O’Brien, T., & Dragovich, P. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.02.004 · Cited by 258
Kurz, E., Hirsch, C. A., Dalton, T., Shadaloey, S. A., Khodadadi-Jamayran, A., Miller, G., Pareek, S., Rajaei, H., Mohindroo, C., Baydogan, S., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.05.006 · Cited by 258
Andrzejewski, S., Klimcakova, E., Johnson, R. M., Tabariès, S., Annis, M. G., McGuirk, S., Northey, J. J., Chénard, V., Sriram, U., Papadopoli, D. J., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.006 · Cited by 245
Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade
Dai, X., Bu, X., Gao, Y., Guo, J., Hu, J., Jiang, C., Zhang, Z., Xu, K., Duan, J., He, S., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.037 · Cited by 242
Purine metabolism regulates DNA repair and therapy resistance in glioblastoma
Zhou, W., Yao, Y., Scott, A. J., Wilder-Romans, K., Dresser, J. J., Werner, C. K., Sun, H., Pratt, D., Sajjakulnukit, P., Zhao, S. G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17512-x · Cited by 240
Goodwin, P. J., Chen, B. E., Gelmon, K. A., Whelan, T. J., Ennis, M., Lemieux, J., Ligibel, J. A., Hershman, D. L., Mayer, I. A., Hobday, T. J., et al. (2022) · JAMA · doi:10.1001/jama.2022.6147 · Cited by 240
ACLY facilitates colon cancer cell metastasis by CTNNB1
Wen, J., Min, X., Shen, M., Hua, Q., Han, Y., Zhao, L., Liu, L., Huang, G., Liu, J., & Zhao, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1391-9 · Cited by 232
Ricciardi, M. R., Mirabilii, S., Allegretti, M., Licchetta, R., Calarco, A., Torrisi, M. R., Foà, R., Nicolai, R., Peluso, G., & Tafuri, A. (2015) · Blood · doi:10.1182/blood-2014-12-617498 · Cited by 222
Sallan, S. E., Hitchcock‐Bryan, S., Gelber, R. D., Cassady, J. R., Frei, E., & Nathan, D. (1983) · PubMed · Cited by 220
Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis
Wang, G., Qiu, M., Xing, X., Zhou, J., Yao, H., Li, M., Yin, R., Hou, Y., Li, Y., Pan, S., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abk2756 · Cited by 218
Cytotoxic T-cells mediate exercise-induced reductions in tumor growth
Rundqvist, H., Veliça, P., Barbieri, L., Gameiro, P. A., Bargiela, D., Gojkovic, M., Mijwel, S., Reitzner, S. M., Wulliman, D., Ahlstedt, E., et al. (2020) · eLife · doi:10.7554/elife.59996 · Cited by 216
PHGDH heterogeneity potentiates cancer cell dissemination and metastasis
Rossi, M., Altea-Manzano, P., Demicco, M., Doglioni, G., Bornes, L., Fukano, M., Vandekeere, A., Cuadros, A. M., Fernández-García, J., Riera-Domingo, C., et al. (2022) · Nature · doi:10.1038/s41586-022-04758-2 · Cited by 213
Bidkhori, G., Benfeitas, R., Klevstig, M., Zhang, C., Nielsen, J., Uhlen, M., Boren, J., & Mardinoglu, A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807305115 · Cited by 211
Dietary Approaches to Cancer Therapy
Tajan, M., & Vousden, K. H. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.04.005 · Cited by 201
Roles and molecular mechanisms of physical exercise in cancer prevention and treatment
Wang, Q., & Zhou, W. (2021) · Journal of Sport and Health Science · doi:10.1016/j.jshs.2020.07.008 · Cited by 199
Dwarakanath, B., Singh, D., Banerji, A., Sarin, R., Venkataramana, N., Jalali, R., Vishwanath, P., Mohanti, B., Tripathi, R., Kalia, V., et al. (2009) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.55136 · Cited by 194
Schneider, M. A., Heeb, L., Beffinger, M. M., Pantelyushin, S., Linecker, M., Roth, L., Lehmann, K., Ungethüm, U., Kobold, S., Graf, R., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc8188 · Cited by 186
Developing dietary interventions as therapy for cancer
Taylor, S. R., Falcone, J. N., Cantley, L. C., & Goncalves, M. D. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00485-y · Cited by 185
Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis
Zhu, Z., Du, S., Du, Y., Ren, J., Ying, G., & Yan, Z. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14250 · Cited by 175
Creatine promotes cancer metastasis through activation of Smad2/3
Zhang, L., Zhu, Z., Yan, H., Wang, W., Wu, Z., Zhang, F., Zhang, Q., Shi, G., Du, J., Cai, H., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.009 · Cited by 173
CPT1A/2-Mediated FAO Enhancement—A Metabolic Target in Radioresistant Breast Cancer
Han, S., Wei, R., Zhang, X., Jiang, N., Fan, M., Huang, J. H., Xie, B., Zhang, L., Miao, W., Butler, A. C.-P., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01201 · Cited by 172
Self-citationMetabolic analysis as a driver for discovery, diagnosis, and therapy
DeBerardinis, R. J., & Keshari, K. R. (2022) · Cell · doi:10.1016/j.cell.2022.06.029 · Cited by 172
NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer
Weiss‐Sadan, T., Ge, M., Hayashi, M., Gohar, M., Yao, C.-H., de Groot, A., Harry, S. A., Carlin, A. D., Fischer, H., Shi, L., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.01.012 · Cited by 172
Deferoxamine for Advanced Hepatocellular Carcinoma
Yamasaki, T., Terai, S., & Sakaida, I. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1105726 · Cited by 170
Kay, E. J., Paterson, K., Riera-Domingo, C., Sumpton, D., Däbritz, J. H. M., Tardito, S., Boldrini, C., Hernandez-Fernaud, J. R., Athineos, D., Dhayade, S., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00582-0 · Cited by 168
Tannir, N. M., Agarwal, N., Porta, C., Lawrence, N. J., Motzer, R. J., McGregor, B. A., Lee, R. J., Jain, R., Davis, N. B., Appleman, L. J., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.3511 · Cited by 168
Li, G., Choi, J. E., Kryczek, I., Sun, Y., Liao, P., Li, S., Wei, S., Grove, S., Vatan, L., Nelson, R., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2022.12.008 · Cited by 168
Sandoval-Acuña, C., Torrealba, N., Tomková, V., Jadhav, S. B., Blažková, K., Merta, L., Lettlová, S., Adamcova, M. K., Rösel, D., Brábek, J., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1628 · Cited by 167
The purine path to chemotherapy
Elion, G. B. (1989) · Bioscience Reports · doi:10.1007/bf01119794 · Cited by 166
GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment
Missiaen, R., Anderson, N. M., Kim, L. C., Nance, B., Burrows, M., Skuli, N., Carens, M., Riscal, R., Steensels, A., Li, F., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.06.010 · Cited by 166
Impact of cancer metabolism on therapy resistance – Clinical implications
Gonçalves, A. C., Richiardone, E., Jorge, J., Polónia, B., Xavier, C. P. R., Salaroglio, I. C., Riganti, C., Vasconcelos, M. H., Corbet, C., & Sarmento-Ribeiro, A. B. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100797 · Cited by 164
Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy
Galli, U., Colombo, G., Travelli, C., Tron, G. C., Genazzani, A. A., & Grolla, A. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00656 · Cited by 162
Role of Glutamine in Protection of Intestinal Epithelial Tight Junctions
Rao, R. K., & Samak, G. (2012) · Journal of Epithelial Biology & Pharmacology · doi:10.2174/1875044301205010047 · Cited by 161
α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer
Tran, T. Q., Hanse, E. A., Habowski, A. N., Li, H., Ishak Gabra, M. B., Yang, Y., Lowman, X. H., Ooi, A. M., Liao, S. Y., Edwards, R. A., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0035-5 · Cited by 161
Hallmarks of Resistance to Immune-Checkpoint Inhibitors
Karasarides, M., Cogdill, A. P., Robbins, P. B., Bowden, M., Burton, E. M., Butterfield, L. H., Cesano, A., Hammer, C., Haymaker, C., Horak, C. E., et al. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0586 · Cited by 160
Lucena-Cacace, A., Otero-Albiol, D., Jiménez-García, M. P., Muñoz-Galvan, S., & Carnero, A. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2575 · Cited by 159
Liu, Y., Ge, J., Chen, Y., Liu, T., Chen, L., Liu, C., Ma, D., Chen, Y., Cai, Y., Xu, Y., et al. (2023) · Advanced Science · doi:10.1002/advs.202205395 · Cited by 159
Self-citationRedox Paradox: A Novel Approach to Therapeutics-Resistant Cancer
Chaiswing, L., Clair, W. H. S., & Clair, D. K. S. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7485 · Cited by 158
Maguire, O. A. B., Ackerman, S. E., Szwed, S. K., Maganti, A. V., Marchildon, F., Huang, X., Kramer, D. J., Rosas-Villegas, A., Gelfer, R., Turner, L. E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.018 · Cited by 157
Yu, T., Yang, G., Hou, Y., Tang, X., Wu, C., Wu, X.-A., Guo, L., Zhu, Q., Luo, H., Du, Y.-E., et al. (2016) · Oncogene · doi:10.1038/onc.2016.370 · Cited by 153
Self-citationDe novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma
Shi, D. D., Savani, M. R., Levitt, M. M., Wang, A. C., Endress, J. E., Bird, C. E., Buehler, J., Stopka, S. A., Regan, M. S., Lin, Y., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.07.011 · Cited by 153
Self-citationSholler, G. L. S., Gerner, E. W., Bergendahl, G., MacArthur, R. B., VanderWerff, A., Ashikaga, T., Bond, J. P., Ferguson, W. S., Roberts, W. D., Wada, R. K., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127246 · Cited by 152
Certain Metabolic and Pharmacologic Effects in Cancer Patients Given Infusions of 2-Deoxy-D-Glucose
Landau, B. R., László, J., Stengle, J. M., & Burk, D. (1958) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/21.3.485 · Cited by 152
Zhang, D., Li, A. M., Hu, G., Huang, M., Yang, F., Zhang, L., Wellen, K. E., Xu, X., Conn, C. S., Zou, W., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.01.010 · Cited by 151
Chlebowski, R. T., Aragaki, A. K., Anderson, G. L., Thomson, C. A., Manson, J. E., Simon, M. S., Howard, B. V., Rohan, T. E., Snetselar, L., Lane, D. S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.72.0326 · Cited by 149
de Botton, S., Montesinos, P., Schuh, A. C., Papayannidis, C., Vyas, P., Wei, A. H., Ommen, H. B., Семочкин, С. В., Kim, H., Larson, R. A., et al. (2022) · Blood · doi:10.1182/blood.2021014901 · Cited by 143
Pomatto, L. C. D., Bodogai, M., Bosompra, O., Kato, J. I., Wong, S., Carpenter, M., Duregon, E., Chowdhury, D., Krishna, P., Ng, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26431-4 · Cited by 135
Tumor-associated macrophages are shaped by intratumoral high potassium via Kir2.1
Chen, S., Cui, W., Chi, Z., Xiao, Q., Hu, T., Ye, Q., Zhu, K., Yu, W., Wang, Z., Yu, C., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.08.016 · Cited by 132
Lin, K., Xie, A., Rutter, J. C., Ahn, Y.-R., Lloyd-Cowden, J. M., Nichols, A., Soderquist, R. S., Koves, T. R., Muoio, D. M., MacIver, N. J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.011 · Cited by 131
Structural basis of mammalian respiratory complex I inhibition by medicinal biguanides
Bridges, H. R., Blaza, J. N., Yin, Z., Chung, I., Pollak, M., & Hirst, J. (2023) · Science · doi:10.1126/science.ade3332 · Cited by 131
Lee, J., Kim, H., Lee, J. E., Shin, S., Oh, S., Kwon, G., Kim, H., Choi, Y. H., White, M. A., Paik, S., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.024 · Cited by 129
Watts, J. M., Baer, M. R., Yang, J., Prébet, T., Lee, S., Schiller, G. J., Dinner, S. N., Pigneux, A., Montesinos, P., Wang, E. S., et al. (2022) · The Lancet Haematology · doi:10.1016/s2352-3026(22)00292-7 · Cited by 129
A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma
Pal, S., Kaplan, J., Nguyen, H. Q., Stopka, S. A., Savani, M. R., Regan, M. S., Nguyen, Q., Jones, K. L., Moreau, L. A., Peng, J., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.07.012 · Cited by 127
Single-cell metabolomics: where are we and where are we going?
Lanekoff, I., Sharma, V. V., & Marques, C. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102693 · Cited by 123
Glycolysis-induced drug resistance in tumors—A response to danger signals?
Marcucci, F., & Rumio, C. (2021) · Neoplasia · doi:10.1016/j.neo.2020.12.009 · Cited by 122
Metabolic Reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids
Pranzini, E., Pardella, E., Paoli, P., Fendt, S., & Taddei, M. L. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.02.004 · Cited by 120
Chung, A. W., Anand, K., Anselme, A. C., Chan, A. A., Gupta, N., Venta, L. A., Schwartz, M. R., Qian, W. P., Xu, Y., Zhang, L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj5070 · Cited by 120
Self-citationBernardes, N., & Fialho, A. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123871 · Cited by 115
Lee, C., Motzer, R. J., Emamekhoo, H., Matrana, M. R., Percent, I. J., Hsieh, J. J.-D., Hussain, A., Vaishampayan, U. N., Liu, S. T., McCune, S. L., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0061 · Cited by 115
Review of various NAMPT inhibitors for the treatment of cancer
Wei, Y., Xiang, H., & Zhang, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.970553 · Cited by 115
Diagnosis and prognosis of breast cancer by high-performance serum metabolic fingerprints
Huang, Y., Du, S., Liu, J., Huang, W., Liu, W., Zhang, M., Li, N., Wang, R., Wu, J., Chen, W., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2122245119 · Cited by 113
The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells
Andreucci, E., Peppicelli, S., Ruzzolini, J., Bianchini, F., Biagioni, A., Papucci, L., Magnelli, L., Mazzanti, B., Stecca, B. A., & Calorini, L. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01959-y · Cited by 106
Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitness
Parida, P. K., Marquez-Palencia, M., Nair, V. R., Kaushik, A., Kim, K., Sudderth, J., Quesada-Diaz, E., Cajigas, Á., Vemireddy, V., Ericsson, P. I. G., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.12.001 · Cited by 105
Metabolomic profiling of rare cell populations isolated by flow cytometry from tissues
DeVilbiss, A., Zhao, Z., Martin-Sandoval, M. S., Ubellacker, J. M., Tasdogan, A., Agathocleous, M., Mathews, T. P., & Morrison, S. J. (2021) · eLife · doi:10.7554/elife.61980 · Cited by 104
Jin, Z., Lu, Y., Wu, X., Pan, T., Yu, Z., Hou, J., Wu, A., Li, J., Yang, Z., Li, C., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102076 · Cited by 104
Voß, M., Wagner, M., von Mettenheim, N., Harter, P. N., Wenger, K. J., Franz, K., Bojunga, J., Vetter, M., Gerlach, R., Glatzel, M., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.06.021 · Cited by 103
Philip, P. A., Buyse, M. E., Alistar, A. T., Lima, C. M. S. R., Luther, S., Pardee, T. S., & Cutsem, E. V. (2019) · Future Oncology · doi:10.2217/fon-2019-0209 · Cited by 102
p63 and SOX2 Dictate Glucose Reliance and Metabolic Vulnerabilities in Squamous Cell Carcinomas
Hsieh, M.-H., Choe, J. H., Gadhvi, J. G., Kim, Y. J., Arguez, M. A., Palmer, M., Gerold, H., Nowak, C. M., Do, H., Mazambani, S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.027 · Cited by 99
Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Maese, L. D., & Rau, R. E. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.902117 · Cited by 99
Perez, R. P., Riese, M. J., Lewis, K. D., Saleh, M. N., DAUD, A. I., Berlin, J. D., Lee, J. J., Mukhopadhyay, S., Zhou, L., Serbest, G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.3003 · Cited by 95
Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in Gastric Cancer Patients
Wang, J., Kunzke, T., Prade, V. M., Shen, J., Buck, A., Feuchtinger, A., Haffner, I., Luber, B., Liu, D. H. W., Langer, R., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-4383 · Cited by 90
S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells
Strekalova, E., Malin, D., Weisenhorn, E., Russell, J. D., Hoelper, D., Jain, A. Y., Coon, J. J., Lewis, P. W., & Cryns, V. L. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05146-7 · Cited by 89
Weinstabl, H., Treu, M., Rinnenthal, J., Zahn, S. K., Ettmayer, P., Bader, G., Dahmann, G., Kessler, D., Rumpel, K., Mischerikow, N., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00718 · Cited by 87
Thomas, D., Wu, M., Nakauchi, Y., Zheng, M., Thompson-Peach, C. A. L., Lim, K. S., Landberg, N., Köhnke, T., Robinson, N., Kaur, S., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0218 · Cited by 77
Fasting and fasting mimicking diets in cancer prevention and therapy
Blaževitš, O., Tano, M. D., & Longo, V. D. (2023) · Trends in cancer · doi:10.1016/j.trecan.2022.12.006 · Cited by 77
Chen, Y., Ge, J., Zhu, S., Shao, Z., & Yu, K. (2022) · Nature Communications · doi:10.1038/s41467-022-28452-z · Cited by 72
Self-citationGao, Y., Li, J., Xi, H., Cui, J., Zhang, K., Zhang, J., Zhang, Y., Xu, W. M., Liang, W., Zhuang, Z., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0827-5 · Cited by 71
Chen, D., Zhang, Y., Wang, W., Chen, H., Ling, T., Yang, R., Wang, Y., Duan, C., Liu, Y., Guo, X., et al. (2021) · Advanced Science · doi:10.1002/advs.202100311 · Cited by 71
Self-citationObesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectives
Barone, I., Caruso, A., Gelsomino, L., Giordano, C., Bonofiglio, D., Catalano, S., & Andò, S. (2021) · Obesity Reviews · doi:10.1111/obr.13358 · Cited by 69
Liu, X., Miao, W., Huang, M., Li, L., Dai, X., & Wang, Y. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001576 · Cited by 68
Self-citationYu, T., Liu, Y., Li, X., Lian, B., Lu, X., Jin, X., Shao, Z., Hu, X., Di, G., & Jiang, Y. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0747 · Cited by 63
Self-citationInhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present
Huff, S. E., Winter, J. M., & Dealwis, C. G. (2022) · Biomolecules · doi:10.3390/biom12060815 · Cited by 61
Egan, G., Khan, D. H., Lee, J. B., Mirali, S., Zhang, L., & Schimmer, A. D. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1227 · Cited by 53
Energy and caloric restriction, and fasting and cancer: a narrative review
Ibrahim, E. M., Al‐Foheidi, M., & Al-Mansour, M. M. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05879-y · Cited by 52
Lu, W.-Q., Hu, Y.-Y., Lin, X.-P., & Fan, W. (2017) · Oncotarget · doi:10.18632/oncotarget.17396 · Cited by 49
Clinical development of IDH1 inhibitors for cancer therapy
Zarei, M., Hue, J. J., Hajihassani, O., Graor, H. J., Katayama, E., Loftus, A. W., Bajor, D. L., Rothermel, L. D., Gohar, A. V., & Winter, J. M. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102334 · Cited by 40
Liao, C., Glodowski, C. R., Fan, C., Liu, J., Mott, K. R., Kaushik, A., Vu, H., Locasale, J. W., McBrayer, S. K., DeBerardinis, R. J., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-2745 · Cited by 39
Cited by
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Tufail, M., Jiang, C.-H., & Li, N. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02119-3 · Cited by 534
Advances in molecular pathology and therapy of non-small cell lung cancer
Huang, Q., Li, Y., Huang, Y., Wu, J., Bao, W., Xue, C., Li, X., Dong, S., Dong, Z., & Hu, S. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02243-6 · Cited by 197
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma, X., Huang, T., Chen, X., Li, Q., Liao, M., Fu, L., Huang, J., Yuan, K., Wang, Z., & Zeng, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02104-8 · Cited by 133
Keoh, L. Q., Chiu, C.-F., & Ramasamy, T. S. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10956-y · Cited by 66
“Given the complex - ity of mitochondrial metabolism and the multiple enzymatic targets within the ETC, several other OXPHOS inhibitors such as phenformin, IACS-010759, IM156, BAY87-2243, ME-344 and VLX600 are under evaluation [85].”
The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities
Cordani, M., Michetti, F., Zarrabi, A., Zarepour, A., Rumio, C., Strippoli, R., & Marcucci, F. (2024) · Neoplasia · doi:10.1016/j.neo.2024.101076 · Cited by 40
Metadata
- Authors
- Xiao, Y., Yu, T.-J., Xu, Y., Ding, R., Wang, Y.-P., Jiang, Y.-Z., & Shao, Z.-M.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2023-08
- Volume
- 35
- Issue
- 8
- Pages
- 1283-1303
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W4385667538
- Cited by
- 256
- References
- 212
- FWCI
- 25.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.